NIH-funded research R01 grant

Investigating the genetics of idiopathic hypersomnia across species

Official title: A cross-species approach to hypersomnia genetics informed by human GWAS

Funded at University of Pennsylvania · NIH-10981595 · Data updated 2026-11-12

This study is looking into the genetic causes of idiopathic hypersomnia, a condition that makes you really sleepy during the day even if you’ve slept well at night, to help find better treatments for people living with it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startAugust 15, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$495,816
NIH project number1R01NS135075-01A1
Project IDNIH-10981595 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with idiopathic hypersomnia or those experiencing excessive daytime sleepiness.

Less likely to help

Patients with hypersomnia due to other known medical conditions may not benefit from this research.

What this research studies

This research focuses on idiopathic hypersomnia (IH), a condition marked by excessive daytime sleepiness despite adequate nighttime sleep. The study aims to uncover the genetic underpinnings of IH by utilizing genome-wide association studies (GWAS) and advanced techniques like ATAC-seq to identify genes linked to hypersomnia traits. By validating these findings in model organisms such as fruit flies and zebrafish, the research seeks to enhance our understanding of IH and improve treatment options for patients. The goal is to bridge the gap between genetic data and practical applications in managing this disorder.

Why it matters

Potential benefit: If successful, this research could lead to better-targeted treatments for patients suffering from idiopathic hypersomnia.

How similar studies have gone: Previous research has shown promise in understanding sleep disorders through genetic approaches, indicating potential for success in this novel investigation.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Chesi, Alessandra — University of Pennsylvania
  • Study coordinator: Chesi, Alessandra

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.